Patients with PD-L1-negative non-small cell lung cancer experienced longer progression-free survival with sac-TMT plus ...
For National Hospice and Palliative Care Month, answers to common questions about how palliative care differs from hospice, ...
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for ...
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains ...
HealthCare.gov open enrollment runs Nov. 1, 2026, to Jan. 15, 2027, and the 2027 out-of-pocket ceiling rises to $12,000. Here ...
After nearly a year of chemotherapy, a patient with stage 4 pancreatic cancer describes daily life and side effects on ...
For Lung Cancer Awareness Month, answers to common patient questions about biomarker testing in non-small cell lung cancer: ...
A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take ...
After a blood cancer diagnosis, a survivor reflects on the close friends who let her be herself and asks whether she is the ...
From a new chemotherapy combination to the first RAS-targeted pill, here's what five years of pancreatic cancer approvals mean for patients.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results